News

The PCI team never stops innovating. Stay informed about our latest achievements.

Avoiding FDA Drug Rescissions: Sponsors Seek CDMOs With Strong Regulatory Track Records

Tags: API Manufacturing | Blog | FDA | GDUFA

Posted February 24, 2020
How Seqens North America Sustains a 96% On-Time Delivery Rate

Tags: API Manufacturing | CDMO | SEQENS

Posted February 17, 2020
How Well Do You Know Your CDMO’s Manufacturing Capacity?

Tags: API Manufacturing | Blog | Equipment | Impurities

Posted February 10, 2020
Things You Should Know About Phase 1 API Manufacturing

Tags: API Manufacturing | Blog | Quality Systems

Posted February 3, 2020
Shattering Five Myths about CDMOs

Tags: API Manufacturing | Blog | CDMO

Posted January 24, 2020
Seqens North America Identifies Trends Affecting the Generic Drugs Sector in 2020

Tags: Manufacturing Trends | Press Releases

Posted January 15, 2020
Key Considerations When Manufacturing APIs for Injectables

Tags: Blog | CDMO | injectables

Posted January 13, 2020
Opportunities Created by the Growing Convergence of Food and Pharmaceuticals

Tags: Blog | Pharma Food

Posted January 6, 2020
Demand Uncertainty? Why More Pharmaceutical Companies are Turning to More Flexible CDMOs

Tags: API Manufacturing | Blog | Targeted Therapies

Posted December 28, 2019
Best Ways to Keep GMP Polymer Projects on Schedule

Tags: Blog | Medical Polymers | polymer synthesis

Posted December 21, 2019